Showing 300 - 308 of 308
View by: Cover Page List Articles
-
The Suppression of Immune System Disorders by Passive Attrition
published 16 Mar 2010
Loading metrics information...
Metrics unavailable. Please check back later.
-
Echinocandin Treatment of Pneumocystis Pneumonia in Rodent Models Depletes Cysts Leaving Trophic Burdens That Cannot Transmit the Infection
published 29 Jan 2010
Loading metrics information...
Metrics unavailable. Please check back later.
-
Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
published 27 Jan 2010
Loading metrics information...
Metrics unavailable. Please check back later.
-
Dynamic Interaction between STLV-1 Proviral Load and T-Cell Response during Chronic Infection and after Immunosuppression in Non-Human Primates
published 25 Jun 2009
Loading metrics information...
Metrics unavailable. Please check back later.
-
Immunosuppression during Acute Infection with Foot-and-Mouth Disease Virus in Swine Is Mediated by IL-10
published 21 May 2009
Loading metrics information...
Metrics unavailable. Please check back later.
-
Interplay between Virus-Specific Effector Response and Foxp3+ Regulatory T Cells in Measles Virus Immunopathogenesis
published 25 Mar 2009
Loading metrics information...
Metrics unavailable. Please check back later.
-
Suppression of HIV-Specific and Allogeneic T Cell Activation by Human Regulatory T Cells Is Dependent on the Strength of Signals
published 13 Aug 2008
Loading metrics information...
Metrics unavailable. Please check back later.
-
Immunological Monitoring of Renal Transplant Recipients to Predict Acute Allograft Rejection Following the Discontinuation of Tacrolimus
published 16 Jul 2008
Loading metrics information...
Metrics unavailable. Please check back later.
-
Ex Vivo Generation of Human Alloantigen-Specific Regulatory T Cells from CD4posCD25high T Cells for Immunotherapy
published 21 May 2008
Loading metrics information...
Metrics unavailable. Please check back later.
Connect with Us